Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lensar Inc (NQ: LNSR )

2.830 +0.150 (+5.60%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,674
Open 2.708
Bid (Size) 2.790 (2)
Ask (Size) 2.830 (12)
Prev. Close 2.680
Today's Range 2.708 - 2.840
52wk Range 2.150 - 8.800
Shares Outstanding 11,023,304
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Friday
  OnFriday, 143 stocks hit new 52-week lows. 
Via Benzinga
LENSAR Earnings Perspective: Return On Capital Employed
 
Via Benzinga

Performance

YTD
+3.66%
+3.66%
1 Month
+4.81%
+4.81%
3 Month
-45.99%
-45.99%
6 Month
-55.71%
-55.71%
1 Year
-51.79%
-51.79%

More News

Read More
LENSAR: Q2 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
LENSAR to Present at Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Why Lensar Shares Are Trading Higher Today
Via Benzinga
Recap: LENSAR Q1 Earnings
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022
From LENSAR, Inc.
Via Business Wire
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU
From LENSAR, Inc.
Via Business Wire
LENSAR Earnings Perspective: Return On Capital Employed
Via Benzinga
First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Earnings Outlook For LENSAR
Via Benzinga
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
From LENSAR, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System
From LENSAR, Inc.
Via Business Wire
LENSAR's Return On Capital Employed Overview
Via Benzinga
LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Earnings Scheduled For May 9, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.